- InVivo Therapeutics Appoints Christopher McNulty as Vice President, Business Development
- InVivo responds to November 17, 2013 Boston Globe article
- InVivo Therapeutics Lead Program on Track
- InVivo Therapeutics Reports Third Quarter 2013 Financial Results
- InVivo Therapeutics Appoints Lou Vaickus, MD as Interim Chief Medical Officer
Developing Technology For
The Treatment of Spinal Cord Injuries
InVivo Therapeutics Corporation is developing and intends to commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI). InVivo intends to leverage its platform technology to deliver several products to the market.